Prestige Consumer Healthcare (NYSE:PBH) Hits New 1-Year High at $75.31

Prestige Consumer Healthcare Inc. (NYSE:PBH - Get Free Report)'s share price hit a new 52-week high on Wednesday . The stock traded as high as $75.31 and last traded at $75.18, with a volume of 124587 shares trading hands. The stock had previously closed at $74.09.

Analyst Ratings Changes

Several analysts have recently weighed in on PBH shares. StockNews.com lowered shares of Prestige Consumer Healthcare from a "strong-buy" rating to a "buy" rating in a research report on Tuesday, May 21st. Canaccord Genuity Group restated a "buy" rating and issued a $80.00 price target on shares of Prestige Consumer Healthcare in a research report on Tuesday, May 21st. Finally, DA Davidson boosted their price target on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a "buy" rating in a research report on Wednesday, August 28th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $98.75.

Prestige Consumer Healthcare Stock Performance

The stock has a market capitalization of $3.74 billion, a price-to-earnings ratio of 18.11, a price-to-earnings-growth ratio of 2.11 and a beta of 0.48. The company has a quick ratio of 1.90, a current ratio of 3.23 and a debt-to-equity ratio of 0.65. The stock's 50-day simple moving average is $69.93 and its 200 day simple moving average is $69.33.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last announced its earnings results on Thursday, August 8th. The company reported $0.90 earnings per share for the quarter, topping analysts' consensus estimates of $0.86 by $0.04. Prestige Consumer Healthcare had a net margin of 18.43% and a return on equity of 12.55%. The company had revenue of $267.10 million during the quarter, compared to the consensus estimate of $260.54 million. During the same period in the previous year, the firm posted $1.06 earnings per share. The company's revenue was down 4.4% on a year-over-year basis. Analysts expect that Prestige Consumer Healthcare Inc. will post 4.42 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Prestige Consumer Healthcare

Institutional investors have recently modified their holdings of the stock. Covestor Ltd lifted its holdings in Prestige Consumer Healthcare by 21.6% in the first quarter. Covestor Ltd now owns 834 shares of the company's stock valued at $61,000 after buying an additional 148 shares during the period. Evergreen Capital Management LLC lifted its holdings in Prestige Consumer Healthcare by 5.4% in the second quarter. Evergreen Capital Management LLC now owns 3,143 shares of the company's stock valued at $216,000 after buying an additional 160 shares during the period. Miller Howard Investments Inc. NY lifted its holdings in Prestige Consumer Healthcare by 2.2% in the second quarter. Miller Howard Investments Inc. NY now owns 7,762 shares of the company's stock valued at $534,000 after buying an additional 165 shares during the period. EverSource Wealth Advisors LLC lifted its holdings in Prestige Consumer Healthcare by 80.6% in the first quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company's stock valued at $33,000 after buying an additional 208 shares during the period. Finally, Parallel Advisors LLC lifted its holdings in Prestige Consumer Healthcare by 42.5% in the fourth quarter. Parallel Advisors LLC now owns 714 shares of the company's stock valued at $44,000 after buying an additional 213 shares during the period. 99.95% of the stock is owned by institutional investors.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.